Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumabNasir Abbas, Jostein Dahle, Jørgen Borrebæk et al.|EJNMMI Research|2011Cited by 57
Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate 227Th-rituximabJostein Dahle, Roy H. Larsen, Thora J. Jónasdóttir et al.|European Journal of Nuclear Medicine and Molecular Imaging|2009Cited by 43
Treatment of HER2-Expressing Breast Cancer and Ovarian Cancer Cells With Alpha Particle-Emitting 227Th-TrastuzumabHelèn Heyerdahl, Jostein Dahle, Cecilie Krogh et al.|International Journal of Radiation Oncology*Biology*Physics|2011Cited by 42